Bordetella pertussis isolates in Finland: serotype and fimbrial expression
about
The Bordetella pertussis model of exquisite gene control by the global transcription factor BvgAResurgence of pertussis calls for re-evaluation of pertussis animal models.Investigating genome reduction of Bordetella pertussis using a multiplex PCR-based reverse line blot assay (mPCR/RLB).Genetic analysis of Bordetella pertussis isolates from the 2008-2010 pertussis epidemic in Japan.Strain variation among Bordetella pertussis isolates circulating in Poland after 50 years of whole-cell pertussis vaccine use.Antibody responses to individual Bordetella pertussis fimbrial antigen Fim2 or Fim3 following immunization with the five-component acellular pertussis vaccine or to pertussis disease.Bordetella pertussis strain variation and evolution postvaccination.Antibody responses to Bordetella pertussis Fim2 or Fim3 following immunization with a whole-cell, two-component, or five-component acellular pertussis vaccine and following pertussis disease in children in Sweden in 1997 and 2007.Epidemiology of whooping cough & typing of Bordetella pertussis.Bordetella pertussis fimbriae (Fim): relevance for vaccines.Appearance of Bordetella pertussis strains not expressing the vaccine antigen pertactin in Finland.Genotypic and phenotypic characterization of Bordetella pertussis strains used in different vaccine formulations in Latin America.Bordetella Pertussis virulence factors in the continuing evolution of whooping cough vaccines for improved performance.Surveillance of Circulating Bordetella pertussis Strains in Europe during 1998 to 2015
P2860
Q27027337-873B6A74-E913-495B-819D-F34DFAF172CAQ34311615-3C35D6BF-4526-4489-AE98-7D968710A366Q34402207-F696CFFB-CB2B-43F8-9846-A50560283B9AQ35017107-5414A45A-A1FC-489E-AACB-CBFE2DB0E89BQ35067167-8DEBE500-CD4B-4C4E-99C9-A1538386408BQ36378615-FC7917C1-0B9F-420F-94D7-47ECEE20B5EDQ37524032-CFF7D797-0B5F-44F0-80CD-64BEB46934B3Q37545016-5055549C-702D-40F8-9B97-AA98F6B154A3Q38160533-07FE0FF6-512B-42FD-90E9-E75A1F22AE75Q38237862-8AB07DF0-1C61-4C08-8ED7-65BC2E4BAD4CQ42386165-CD3E0B37-AB14-4194-BA08-1285A21B97ADQ42642555-ABEB3AE7-7385-449D-A46E-79588D31B21FQ49822345-BAF02A61-39C6-4227-AD77-8DA92E73B83CQ57102695-69AF1C9D-5EDA-41E1-A9DE-15430920075D
P2860
Bordetella pertussis isolates in Finland: serotype and fimbrial expression
description
2008 nî lūn-bûn
@nan
2008 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Bordetella pertussis isolates in Finland: serotype and fimbrial expression
@ast
Bordetella pertussis isolates in Finland: serotype and fimbrial expression
@en
type
label
Bordetella pertussis isolates in Finland: serotype and fimbrial expression
@ast
Bordetella pertussis isolates in Finland: serotype and fimbrial expression
@en
prefLabel
Bordetella pertussis isolates in Finland: serotype and fimbrial expression
@ast
Bordetella pertussis isolates in Finland: serotype and fimbrial expression
@en
P2093
P2860
P50
P356
P1433
P1476
Bordetella pertussis isolates in Finland: serotype and fimbrial expression
@en
P2093
Dorothy K Xing
Eriikka Heikkinen
Matti K Viljanen
Rose-Marie Olander
P2860
P2888
P356
10.1186/1471-2180-8-162
P577
2008-09-25T00:00:00Z
P5875
P6179
1025043296